EUVIMEDEUVIMED entdecken
Crossref

MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer

Vahid Tavakolpour, Mahboubeh Safari-Kharkeshi, Hamid Reza Soleimanpour-Lichaei, Mossa Gardaneh, Fatemeh Kouhkan

Gene Reports · 2025-09 · 40 · 102211

DOI: 10.1016/j.genrep.2025.102211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene Reports, 2025-09. Verfasst von Vahid Tavakolpour und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Institute for Genetic Engineering and Biotechnology, Iran National Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Institute for Genetic Engineering and Biotechnology
  • Iran National Science Foundation

Zitieren

APA

Tavakolpour, V., Safari-Kharkeshi, M., Soleimanpour-Lichaei, H. R., Gardaneh, M., & Kouhkan, F. (2025). MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer. Gene Reports, 40, 102211. https://doi.org/10.1016/j.genrep.2025.102211

Vancouver

Tavakolpour V, Safari-Kharkeshi M, Soleimanpour-Lichaei HR, Gardaneh M, Kouhkan F. MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer. Gene Reports. 2025;40:102211. doi:10.1016/j.genrep.2025.102211

BibTeX
@article{Tavakolpour2025,
  author = {Tavakolpour, Vahid and Safari-Kharkeshi, Mahboubeh and Soleimanpour-Lichaei, Hamid Reza and Gardaneh, Mossa and Kouhkan, Fatemeh},
  title = {MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer},
  journal = {Gene Reports},
  year = {2025},
  volume = {40},
  pages = {102211},
  doi = {10.1016/j.genrep.2025.102211}
}
Kostenlos starten →